“Europe has exceptional science but struggles with translation. The reasons are structural. First, the financial models commonly used– especially venture capital – are misaligned with the capital intensity and timelines of deep industrial innovation.”. To say it – in this interview with Il Bioeconomista – is Massimo Portincaso, CEO Arsenale Bioyards, the Italy-headquartered company with a proprietary end-to-end platform that makes biomanufacturing via precision fermentation economically viable
at industrial scale – for the very first time.
Interview by Mario Bonaccorso
IL BIOECONOMISTA 